Products

A product is the point at which values meet a barcode. The vegan product landscape is the set of goods — edible, wearable, cosmetic, domestic, and animal-adjacent — that carry the values of veganism across the checkout line. It spans three distinct strata: reformulated versions of familiar products (oat milk, vegan cheese, PU-coated handbags), novel categories enabled by new biology (mycelium leather, precision-fermented whey, cultivated chicken), and infrastructural goods like certifications that let buyers verify any of the above without reading an ingredient panel.

This page is the trunk of the products pillar on veganism.wiki. It maps the major categories, summarizes the certification ecosystem that governs labelling, reviews the market-size picture from Bloomberg Intelligence, GFI, Euromonitor, and SPINS, and sketches the innovation vectors — precision fermentation, cultivated meat, biomaterials — that are likely to reshape the category over the next decade.

The shape of the category

Vegan products are defined by the absence of animal ingredients and, in the stricter standards, by the absence of animal testing at any stage. That negative definition obscures how wide the category actually is. Food is the largest and most visible slice, but the full landscape includes clothing and footwear, cosmetics and personal care, cleaning and household goods, pharmaceuticals and supplements, pet food, and a growing body of home and industrial materials (adhesives, upholstery, films, coatings) whose animal content most consumers never notice.

Two forces expand the category. The first is reformulation — the replacement of tallow in soap, gelatin in capsules, carmine in beverages, shellac on apples, or casein in paint with plant-based or synthetic equivalents. The second is invention, where categories that did not previously exist (cultivated meat, mycelium leather, microbial egg white) emerge from biotechnology and displace the animal-derived original altogether (Rubio, Xiang & Kaplan, 2020). The existing category grows through substitution; the frontier grows through creation.

Food: meat, dairy, and egg alternatives

Food is where the vegan product landscape is deepest. The Good Food Institute’s State of the Industry reports segment the market into plant-based meat, seafood, dairy, and eggs, each with distinct trajectories (GFI, 2023a).

Plant-based meat has moved from extruded soy patties to a dense innovation stack of proteins (pea, soy, fava, wheat, rice, mycoprotein, potato), fats (coconut, cocoa butter, sunflower, encapsulated oils), binders, and flavour systems designed to mimic the sensory experience of animal tissue (Knaapila et al., 2022). SPINS retail data show the U.S. plant-based meat category at roughly $1.2 billion in annual retail sales in 2023, down modestly from a 2020 peak after a period of hypergrowth (SPINS / PBFA, 2023). Category maturity — and the shakeout of second-tier brands — is a normal phase, not a reversal.

Plant-based dairy is the larger and more stable slice. Plant-based milks account for roughly 15% of the total U.S. fluid milk category by dollar sales, with oat, almond, and soy dominant (SPINS / PBFA, 2023). Cheese, yogurt, butter, ice cream, and creamers follow at lower but rising penetration. Precision fermentation — covered below — is increasingly the technology reshaping the quality ceiling in this segment, by producing real whey and casein proteins without cows.

Egg alternatives range from liquid mung-bean emulsions used in scrambles and baking to microbial egg-white proteins produced by fermentation. The category is small in absolute dollars but strategically important because eggs are a functional ingredient in thousands of downstream products — a replacement that works at industrial scale moves far more animal-derived volume than a direct-to-consumer carton ever would.

Seafood alternatives remain the least developed food segment. Plant-based tuna, salmon, shrimp, and whitefish products exist, but per-capita spend and shelf share are small compared with meat and dairy. Cultivated seafood and mycelium-based whole-cuts are the two most active innovation fronts here.

Clothing: leather, wool, silk, down, and fur

The non-food material economy is structurally different. Animal-derived materials in fashion are fewer in kind (leather, wool, silk, down, fur, cashmere, some exotic skins) but deeper in cultural entrenchment, and their alternatives sit at different stages of maturity.

Leather is the largest by volume. Synthetic leathers — historically polyurethane (PU) and polyvinyl chloride (PVC) coatings over textile backings — account for most of the world’s “leather-look” output (Textile Exchange, 2023). The environmental case for leather has been challenged directly by Circumfauna and Collective Fashion Justice (2022), whose analysis argues that bovine leather’s land-use, emissions, and tanning impacts exceed those of most synthetic alternatives on a life-cycle basis, contradicting the industry’s “by-product” framing. The frontier category is bio-based leather — mycelium (Mylo, Reishi), cactus (Desserto), pineapple-leaf (Piñatex), apple-pomace, and grape-marc composites — which aims to replace both animal leather and petrochemical PU with materials grown or composted from agricultural side-streams.

Wool alternatives include recycled synthetics (polyester, nylon), cellulosics (Tencel, viscose), cotton, hemp, and emerging plant-protein fibres; each has trade-offs in warmth, breathability, biodegradability, and microfibre shedding. Silk is increasingly addressed through Bolt Threads’ and Spiber’s recombinant spider-silk and microbial-silk technologies and through plant-cellulose filaments. Down is replaced by recycled polyester fills, kapok, and newer plant-composite insulations. Fur, regulated and banned in a growing list of jurisdictions, is the category where market share has most clearly collapsed in favour of synthetic and faux alternatives.

Cosmetics and personal care: two labels, one shelf

Cosmetics is the category where “vegan” and “cruelty-free” most often diverge, and consumers frequently conflate them. The two labels answer different questions.

“Cruelty-free” refers to animal testing. The Leaping Bunny standard, run by the Coalition for Consumer Information on Cosmetics, requires that a company commit to no animal testing at any stage — raw materials, formulation, or finished product — by itself, its suppliers, or any third party, with a supplier-monitoring system and independent audits (CCIC, 2023). PETA’s Beauty Without Bunnies program operates a parallel standard built on a company’s statement of assurance, with separate “cruelty-free” and “cruelty-free and vegan” tiers (PETA, 2023).

“Vegan” refers to ingredients. A product is vegan when it contains no animal-derived substances — no beeswax, lanolin, carmine, keratin, silk, collagen, tallow, or milk-derived actives — and is often additionally required, under stricter marks, to be produced without animal testing. A product can be cruelty-free but not vegan (tested on no animals but containing honey or lanolin), and, in rare cases, vegan but not cruelty-free (plant-ingredient only, but sold in jurisdictions that mandate animal testing for registration).

The regulatory backdrop has moved rapidly. The European Union banned animal testing for cosmetic ingredients in 2013; the United Kingdom, Israel, India, Australia, and a growing list of Latin American and U.S. states have followed, and China — long the pivotal market requiring animal testing for imported cosmetics — has incrementally relaxed mandatory testing for most ordinary cosmetics since 2021 (Humane Society International, 2023). The trajectory is toward a global default of non-animal testing, which re-centres the vegan question on ingredients.

Household, pharmaceuticals, and pet food

Household goods are the category most consumers underestimate. Cleaning products, candles, detergents, polishes, and paints routinely contain tallow, beeswax, casein, or animal-derived surfactants; many are also tested on animals by component suppliers. Vegan-certified household brands — Method, Ecover, Attitude, Dr. Bronner’s, among others — have grown alongside the plant-based food category, often carrying Leaping Bunny or Vegan Trademark marks.

Pharmaceuticals and supplements are a harder space. Gelatin capsules, lactose excipients, lanolin-derived vitamin D3, and animal-sourced glucosamine, chondroitin, omega-3s, and hormones remain widespread. Plant-cellulose capsules, lichen-derived D3, algal DHA/EPA, and fermentation-produced insulin and collagen are the substitution paths, but regulatory inertia and legacy formulations mean conversion is slow. For strict vegans, pharmaceuticals sit inside the “as far as possible and practicable” clause of the Vegan Society definition — medicine that preserves life is not the place ideological purity is enforced.

Pet food is the most philosophically contested sub-category. Dogs are facultative omnivores and can thrive on well-formulated plant-based diets; cats are obligate carnivores whose requirements (taurine, arachidonic acid, preformed vitamin A, specific amino acids) are more demanding but increasingly met by fortified plant and fermentation-derived formulas. Grand View Research (2023) sized the global vegan pet food market at roughly $10 billion, growing at a double-digit rate, driven by consumer values and by a separate set of environmental arguments about the footprint of feeding livestock to companion animals.

Certifications: the trust infrastructure

Because “vegan” is not a regulated term in most jurisdictions, third-party marks do the verification work. Four marks dominate international shelves.

The Vegan Society’s Vegan Trademark, established in 1990 by the same organisation that coined the word “vegan” in 1944, certifies products as free of animal ingredients and animal testing, with criteria extending to GMO inputs derived from animal genes and to reasonable avoidance of cross-contamination (Vegan Society, 2023). It is the oldest mark and the reference standard in the UK and much of Europe.

V-Label, administered by the European Vegetarian Union, operates a single unified standard with separate “vegetarian” and “vegan” tiers, covers food, cosmetics, textiles, and non-food goods, and conducts on-site audits in most licensing jurisdictions (V-Label, 2023). It is the most widely recognised mark in continental Europe and has expanded globally.

Leaping Bunny, run by the CCIC in North America and Cruelty Free International in the UK and Europe, is the gold standard for cruelty-free certification in cosmetics, personal care, and household products. It does not certify veganism directly but is frequently paired with a vegan mark (CCIC, 2023).

PETA’s Beauty Without Bunnies offers a statement-of-assurance-based model with “cruelty-free” and “cruelty-free and vegan” tiers. It has the widest brand coverage by count but a lighter verification model than Leaping Bunny or V-Label (PETA, 2023).

Beyond these four, national and sectoral marks (Certified Vegan in the U.S., EVE Vegan in France, ISO-aligned technical standards in development) fill specific niches. The multiplication of marks is a predictable market response to ambiguous regulation; consolidation is likely as retailers and regulators converge on a smaller number of credible standards.

The market-size picture

Three data sources together describe the market. Bloomberg Intelligence (2021) projected that plant-based food would reach $162 billion globally by 2030, roughly 7.7% of the total protein market, up from $29 billion in 2020 — a forecast built on category penetration, demographic tailwinds, and an expected continuation of the 2019–2021 growth rate. Subsequent category cooling has put the exact trajectory under debate, but the order-of-magnitude conclusion — that plant-based is on track to become a double-digit share of the protein category within a decade — remains broadly intact in Euromonitor and GFI tracking.

Euromonitor International’s retail data places global plant-based food retail value in the low tens of billions of dollars annually, with the highest per-capita spend in Western Europe, North America, and Australia and the fastest growth rates in parts of Asia and Latin America (Euromonitor, 2023). GFI’s State of the Industry reports triangulate the same picture from the supply side, aggregating company counts, investment flows, and retail shares across plant-based, fermentation, and cultivated segments (GFI, 2023a, 2023b, 2023c).

Investment tells the forward story. GFI’s fermentation report recorded cumulative investment in alternative-protein fermentation companies exceeding $4 billion through 2023, with precision fermentation attracting the largest share. Cultivated meat investment topped $3 billion cumulatively over the same period, though year-on-year flows have tightened with the broader tech-investment cycle (GFI, 2023b, 2023c). Capital allocation is a leading indicator; category market-share is a lagging one.

Non-food vegan categories are harder to size because they sit inside larger markets (leather-goods, cosmetics, household) rather than as named line-items. Textile Exchange (2023) and Circumfauna (2022) provide the closest proxies for material-level share, showing plant-based and synthetic leather alternatives already accounting for well over half of global “leather-look” output by volume, with bio-based frontier materials still a rounding error but growing fastest.

Innovation vectors

Four technology stacks are reshaping what a vegan product can be.

Plant-protein fractionation and texturisation — higher-performance pea, fava, and chickpea isolates, wet and dry extrusion, shear-cell technology, and 3D-printed whole cuts — continues to raise the sensory ceiling of plant-based meat (Knaapila et al., 2022). The curve is not exhausted; it is just past its first hype wave.

Precision fermentation uses engineered microbes (yeast, fungi, bacteria) to produce specific animal proteins — whey, casein, ovalbumin, collagen, lactoferrin, heme — without animals (GFI, 2023b). Products using these ingredients are already on shelves in U.S. dairy and baking categories, and the technology is the most likely route to cost parity with conventional dairy in the 2020s.

Cultivated meat grows animal muscle and fat from cells in bioreactors, producing biologically animal tissue without slaughter. Regulatory approvals have been granted in Singapore, the United States, and Israel; commercial volumes remain small and cost-reduction is the binding constraint (Rubio et al., 2020; GFI, 2023c). Cultivated is a decade-scale technology; its near-term role is more likely in hybrid products — plant-protein matrix with cultivated fat — than in full-price retail steak.

Biomaterials — mycelium-grown leathers, microbial silks, algae-based films, bacterial-cellulose textiles — extend the same logic beyond food. The fashion industry’s highest-profile collaborations (Stella McCartney, Hermès, Adidas, Lululemon) have centred on mycelium leathers, and the category is the leading edge of how non-food animal-derived materials will be displaced.

What this pillar covers

The sub-articles that branch from this trunk go deeper on each segment:

• plant-based-meat — ingredient systems, texturisation, category economics, and health profiles
• plant-based-dairy — milks, cheeses, yogurts, and the reformulation vs. fermentation split
• egg-alternatives — liquid, whole-egg, and microbial-protein approaches
• cultivated-meat — bioreactor production, regulatory status, cost curves
• precision-fermentation — microbial production of dairy, egg, and specialty proteins
• fashion — leather, wool, silk, down, fur and their bio-based and synthetic alternatives
• cosmetics — cruelty-free vs. vegan, ingredient audits, and the regulatory shift away from animal testing
• certification — Vegan Trademark, V-Label, Leaping Bunny, PETA, and the emerging landscape of national marks
• pet-food — plant-based and fermentation-derived formulations for companion animals
• household-and-pharmaceuticals — the overlooked categories where animal ingredients persist

The throughline is that the vegan product landscape is no longer a specialty shelf. It is a parallel economy — already multi-tens-of-billions of dollars, growing through both substitution and invention, governed by a maturing certification infrastructure, and positioned to absorb large share from animal-derived categories as the underlying biotechnology continues to compound.